Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?

Bibliographic Details
Main Authors: Jaydeep Bhat, Léonce Kouakanou, Christian Peters, Zhinan Yin, Dieter Kabelitz
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/full
_version_ 1818113138864685056
author Jaydeep Bhat
Léonce Kouakanou
Christian Peters
Zhinan Yin
Dieter Kabelitz
author_facet Jaydeep Bhat
Léonce Kouakanou
Christian Peters
Zhinan Yin
Dieter Kabelitz
author_sort Jaydeep Bhat
collection DOAJ
first_indexed 2024-12-11T03:30:04Z
format Article
id doaj.art-1e7112c05d814756a1c87538cc9c87c1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T03:30:04Z
publishDate 2018-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1e7112c05d814756a1c87538cc9c87c12022-12-22T01:22:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-03-01910.3389/fimmu.2018.00512355599Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?Jaydeep Bhat0Léonce Kouakanou1Christian Peters2Zhinan Yin3Dieter Kabelitz4Institute of Immunology, University of Kiel, Kiel, GermanyInstitute of Immunology, University of Kiel, Kiel, GermanyInstitute of Immunology, University of Kiel, Kiel, GermanyThe First Affiliated Hospital, Biomedical Translational Research Institute, Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou, ChinaInstitute of Immunology, University of Kiel, Kiel, Germanyhttp://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/fullBromodomain and ExtraTerminal domaincheckpoint inhibitorsDNA methylationgamma delta T cellshistone acetylationimmunotherapy
spellingShingle Jaydeep Bhat
Léonce Kouakanou
Christian Peters
Zhinan Yin
Dieter Kabelitz
Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
Frontiers in Immunology
Bromodomain and ExtraTerminal domain
checkpoint inhibitors
DNA methylation
gamma delta T cells
histone acetylation
immunotherapy
title Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
title_full Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
title_fullStr Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
title_full_unstemmed Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
title_short Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
title_sort immunotherapy with human gamma delta t cells synergistic potential of epigenetic drugs
topic Bromodomain and ExtraTerminal domain
checkpoint inhibitors
DNA methylation
gamma delta T cells
histone acetylation
immunotherapy
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00512/full
work_keys_str_mv AT jaydeepbhat immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs
AT leoncekouakanou immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs
AT christianpeters immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs
AT zhinanyin immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs
AT dieterkabelitz immunotherapywithhumangammadeltatcellssynergisticpotentialofepigeneticdrugs